Replimune (REPL) Invested Capital (2019 - 2026)

Replimune (REPL) has 8 years of Invested Capital data on file, last reported at $24.8 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 2.88% year-over-year to $24.8 million; the trailing twelve-month figure through Mar 2026 stood at $100.3 million (down 2.65% YoY), and the FY2026 full-year result was $24.8 million, down 2.88% from the prior year.
• Invested Capital declined to $24.8 million in Q1 2026, from $25.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $27.0 million in Q1 2022 to a low of $24.8 million in Q1 2026.
• A 5-year average of $26.0 million and a median of $26.1 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital slipped 1.06% in 2022 and fell 2.88% in 2026, its largest moves.
• Tracing REPL's Invested Capital over 5 years: stood at $26.7 million in 2022, then retreated by 1.67% to $26.3 million in 2023, then declined by 2.16% to $25.7 million in 2024, then decreased by 2.73% to $25.0 million in 2025, then retreated by 0.8% to $24.8 million in 2026.
• Business Quant data shows REPL's Invested Capital at $24.8 million in Q1 2026, $25.0 million in Q4 2025, and $25.2 million in Q3 2025.